Leptin Levels in Papillary Thyroid Cancer
This trial is active, not recruiting.
|Conditions||thyroid cancer, papillary, leptin levels|
|Sponsor||University of Nebraska|
|Start date||August 2012|
|End date||June 2013|
|Trial size||150 participants|
|Trial identifier||NCT01659385, 276-12-EP|
The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.
evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.
time frame: During Study
Female participants from 19 years up to 75 years old.
Inclusion Criteria: - Female - Age>/- 19 - Not currently pregnant or lactating - Normal thyroid gland by history Exclusion Criteria: - Male Gender - Pregnancy - Lactation - Age below 19 - Abnormal thyroid gland by history - Abnormal thyroid gland by structure using ultrasound - Abnormal thyroid gland by function using TSH, Free T4
|Official title||Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls|
|Principal investigator||Whitney Goldner, MD|
|Description||There will be three groups in this study, but 2 of the groups are part of another study so will only recruit normal controls.|
Call for more information